Of note, our frequency of CTNNB1 wild-type WNT-activated medulloblastomas is significantly higher than that reported in North American and European populations, varying from 6.8% (8) to 13% (in silico analysis). This evidence concerns the gene CTNNB1 and medulloblastoma.